AMPAC Fine Chemicals Expands Petersburg, Virginia, Operations Center
05/10/2021
According to city officials, AMPAC Fine Chemicals is a major collaborator in the new U.S. government-funded partnership with Phlow Corporation, Medicines for All Institute, and non-profit drugmaker Civica Inc. Through this partnership, Phlow executed a $354 million contract with the U.S. Biomedical Advanced Research and Development Authority to produce essential medications using advanced manufacturing processes from the Medicines for All Institute based at the College of Engineering at Virginia Commonwealth University.
“Of our three AMPAC locations, Virginia offers an enabling environment for developing and sustaining the growth in capacity and infrastructure demanded for the pharmaceutical industry,” said Dr. William DuBay, AMPAC Global Vice President of Research and Development. “Our growing relationship with the Commonwealth, VEDP, the City of Petersburg, and others, including VCU, Phlow, and Civica, is a cornerstone of our vision for American-based manufacturing of critical pharmaceutical ingredients.”
As an incentive, Virginia Economic Development Partnership (VEDP) worked with the City of Petersburg, Virginia’s Gateway Region, the Community College Workforce Alliance and Dominion Energy to secure the project for the Commonwealth. Governor Northam approved a $640,000 grant from the Commonwealth’s Opportunity Fund to assist the City of Petersburg with the project. The Governor also approved a $250,000 Virginia Investment Performance Grant, a performance-based incentive that encourages continued capital investment by existing Virginia companies. The company is eligible to receive benefits from the Major Business Facility Job Tax Credit for new, full-time jobs created.
“This major expansion boosts the fast-growing pharmaceutical manufacturing campus in Petersburg and is a major win for the region and the Commonwealth,” said Secretary of Commerce and Trade Brian Ball. “We are confident Virginia’s workforce training programs and skilled talent pipeline will ensure AMPAC’s continued success, and applaud the company and its partners for fulfilling the mission to provide quality products to patients everywhere.”
As part of this initiative, city officials said AFC will expand the former Boehringer Ingelheim chemical plant, purchased in 2016, and in operation since 2019. In January, Governor Northam announced that Civica Inc. would invest $124.5 million to establish a new facility adjacent to Phlow’s future operation and AMPAC’s existing facility. The Civica plant will convert active pharmaceutical ingredients from AMPAC and Phlow into vials and syringes of finished medications for use in hospitals.
“Our region is emerging as a pharmaceutical manufacturing cluster and we look forward to supporting AMPAC and its partner companies as they stabilize America’s essential medicine supply chain,” added Keith Boswell, President and CEO of Virginia’s Gateway Region Economic Development Organization added.
Project Announcements
GE Vernova Expands Schenectady, New York, Operations
05/26/2023
Southern Rock Energy Partners Plans Cushing, Oklahoma, Crude Oil Refinery
05/26/2023
ForwardEdge ASIC Establishes St. Paul, Minnesota, Operations
05/26/2023
Spain-Based Cosentino Group Plans Jacksonville, Florida, Manufacturing Plant
05/26/2023
Michelin Expands Junction City, Kansas, Operations
05/26/2023
Italy-Based Alpitronic Americas Plans Charlotte, North Carolina, U.S. Headquarters-Operations
05/25/2023
Most Read
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
19th Annual Consultants Survey: Clients Challenged by Tight Labor Market, Energy Availability
Q1 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Manufacturing and Distribution Trends Impact the Value of Credits and Incentives
Q1 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023